Dr. Nicholas Goldner & Dr. Christopher Bulow – 117

December 8, 2020

Resistance resistance cancer therapies that last longer and hit harder. This is what Nick and Chris from Visoera are currently working on. They’ve been funded, been through YC, and are two amazing scientists turned entrepreneurs. They’ve also been on the show before.

Key links

https://www.viosera.com/

https://www.linkedin.com/in/nicholas-goldner/

https://www.linkedin.com/in/christopherbulow/

info@viosera.com
https://www.youtube.com/watch?v=WQg1qnwtufA

Last episode we did. 

10: Nicholas Goldner, CEO, and Christopher Bulow, COO, of Viosera

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.